PerkinElmer stock slips after $5.25 billion cash and stock deal to buy BioLegend

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Finance Finance Headlines News

Finance Finance Latest News,Finance Finance Headlines

PerkinElmer to buy privately held BioLegend for $5.25 billion

Shares of PerkinElmer Inc. PKI, +2.67% fell 1.3% in premarket trading Monday, after the diagnostics, life science and food company announced an agreement to buy life science discovery and research company BioLegend for $5.25 billion in cash and stock. BioLegend, with 700 employees and based primarily in the U.S., is estimated to have $380 million in revenue in 2022.

PerkinElmer expects the deal, which is anticipated to close by the end of 2021, to add to revenue growth and add an estimated 30 cents to adjusted earnings per share in the first full year after the close, and to add 50 cents to adjusted EPS in the second year. Revenue synergies are expected to reach $100 million a year by the fifth year after the deal's closing. Separately, PerkinElmer reported second-quarter adjusted EPS that rose to $2.83 from $1.57, above the FactSet consensus of $2.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in FİNANCE

Finance Finance Latest News, Finance Finance Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

U.S. investors expect inflation to pick up, prompting these portfolio changes, a UBS survey findsA majority of investors in the U.S. are expecting inflation to pick up, with many planning to buy stocks to adjust for the rise, according to UBS Group’s... thanks
Source: MarketWatch - 🏆 3. / 97 Read more »

Bank earnings preview — pullback gives you an opportunity to buy the stocksShares of the largest U.S. banks have staged a recovery following the stock market’s pandemic low point last year. But they have lagged behind the broader market. Here's a summary of analysts’ opinions about shares of the 12 largest U.S. banks: wow Michael Burry Warns Retail Traders About the 'Mother of All Crashes'
Source: MarketWatch - 🏆 3. / 97 Read more »

Tesla and more: Goldman Sachs names 10 electric vehicle stocks to buy right nowNew for subscribers: Tesla and more: Goldman Sachs names 10 electric vehicle stocks to buy right now. Check out CNBCPro today. Pro Y’all forgot about FSR!
Source: CNBC - 🏆 12. / 72 Read more »

European stocks retreat as investors watch corporate earnings, Covid casesEuropean stocks set for lower open as investors watch corporate earnings, Covid cases thanks You have no idea what investors are doing. Investors is a very broad term. AMC/AH9 looking quite bullish my dudes.
Source: CNBC - 🏆 12. / 72 Read more »